
Keywords: BCP; beta caryophyllene; CCI; chronic constriction injury; CFA; complete freund's adjuvant; CNS; central nervous system; GPCR; G protein-coupled receptor; GRAS; generally recognized as safe; IL-16; interleukin- 16; IL-17R; interleukin- 17R; IL-22; inter